Public Health | November 25, 2021
Gastrointestinal disorders increasing in India
It is estimated that one-third of our country’s population has some form of these disorders
It is estimated that one-third of our country’s population has some form of these disorders
The nutraceutical sector is on the cusp of exponential growth and Covid-19 has accelerated the pace of its applications. Dr R.B Smarta, CMD, Interlink, shares his perspective on the growth opportunities and challenges for the sector
The consideration for the acquisition is US $ 2.25 million
Support from DFC will help produce one billion vaccine doses by the end of 2022
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
Tezepelumab has been granted Orphan Drug Designation (ODD) in the US by the U.S. Food and Drug Administration (FDA) for the treatment of eosinophilic esophagitis (EoE)
The start-up claims in clinical trials over 90 % achieved type 2 diabetes reversal and 92 % eliminated all diabetes medication within 90 days of joining the twin service
The company claims to be a market leader in core orthopaedic and gynaecology segments like bone and joint disorders, pain management and, pregnancy and women’s nutrition
The global wellness market is valued at more than US $ 1.5 trillion, with annual growth of 5-10 per cent
The aspirant can enrol in MBA (Healthcare and Hospital Management) at Ganpat University, -Centre for Management Studies and Research, which will be facilitated by Ganpat University and Shalby Centre for Healthcare Management and Research
Subscribe To Our Newsletter & Stay Updated
